Teva Pharmaceutical Industries (TEVA) Return on Capital Employed Growth (1y) (2010 - 2026)
Teva Pharmaceutical Industries (TEVA) Return on Capital Employed Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | 333.00 |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -469.00 |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 8.00 |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 220.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 802.00 |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | 340.00 |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | 573.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Alkermes | 8.11 Bn | 7.46 Bn | 397.90 Mn | -1,932.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 333.00 |
| Mar 31, 2026 | 696.00 |
| Dec 31, 2025 | 912.00 |
| Sep 30, 2025 | 467.00 |
| Jun 30, 2025 | 24.00 |
| Mar 31, 2025 | 79.00 |
| Dec 31, 2024 | -251.00 |
| Sep 30, 2024 | 578.00 |
| Jun 30, 2024 | 679.00 |
| Mar 31, 2024 | 527.00 |
| Dec 31, 2023 | 814.00 |
| Sep 30, 2023 | -54.00 |
| Jun 30, 2023 | -101.00 |
| Mar 31, 2023 | -608.00 |
| Dec 31, 2022 | -1,140.00 |
| Sep 30, 2022 | -908.00 |
| Jun 30, 2022 | 526.00 |
| Mar 31, 2022 | 1,042.00 |
| Dec 31, 2021 | 1,432.00 |
| Sep 30, 2021 | 1,509.00 |